ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,175Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 1442

$925K Total Retail Price of All Prescriptions

Rank: 24 out of 1442

433 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 12,598 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 652 643 1 2
FUROSEMIDE 580 556 2 5
ATORVASTATIN CALCIUM 568 553 3 4
CLOPIDOGREL 520 496 4 12
AMLODIPINE BESYLATE 505 487 5 3
COUMADIN 485 447 6 41
ATENOLOL 479 438 7 11
METOPROLOL SUCCINATE 413 401 8 1
PLAVIX 413 407 8 14
NEXIUM 384 358 10 34
EVISTA 361 348 11 73
ALLOPURINOL 326 307 12 47
CARVEDILOL 311 304 13 8
LOSARTAN POTASSIUM 305 296 14 13
RANEXA 300 269 15 29
OMEPRAZOLE 255 234 16 21
ISOSORBIDE MONONITRATE ER 243 230 17 17
DIOVAN 231 220 18 19
DIGOXIN 228 199 19 15
CRESTOR 226 223 20 10
METFORMIN HCL 211 206 21 26
ENALAPRIL MALEATE 188 184 22 23
LIPITOR 187 183 23 24
METOPROLOL TARTRATE 182 166 24 6
WARFARIN SODIUM 174 126 25 9
GLIMEPIRIDE 163 163 26 67
DILTIAZEM 24HR CD 146 144 27 59
ALENDRONATE SODIUM 131 128 28 46
POTASSIUM CHLORIDE 128 128 29 33
LEVOTHYROXINE SODIUM 128 116 29 22
PRADAXA 119 118 31 27
VERAPAMIL ER 107 107 32 77
ACTOS 98 89 33 110
TAMSULOSIN HCL 98 95 33 38
CELEBREX 95 95 35 138
PRAVASTATIN SODIUM 92 92 36 20
ZOLPIDEM TARTRATE 91 83 37 25
ZETIA 89 88 38 31
LOVAZA 87 78 39 37
NIFEDIPINE ER 85 85 40 39
LISINOPRIL 85 85 40 7
COLCRYS 76 75 42 135
DIOVAN HCT 73 73 43 35
MECLIZINE HCL 68 68 44 83
TRILIPIX 65 65 45 104
FLUOCINOLONE ACETONIDE 64 64 46 321
HYDROCHLOROTHIAZIDE 62 56 47 16
FAMOTIDINE 62 60 47 70
ULORIC 53 53 49 350
JANUVIA 51 51 50 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.